blood tumor

blood tu·mor

term sometimes used to denote an aneurysm, hemorrhagic cyst, or hematoma.

Farlex Partner Medical Dictionary © Farlex 2012

An obsolete nonspecific term for any blood-filled mass, e.g., hematomata, aneurysms, hemorrhagic cysts

Mentioned in ?

References in periodicals archive ?

Foundation Medicine (FMI) announced the publication of the results of a large study demonstrating that its novel, investigational assay to measure blood tumor mutational burden can help predict response to the anti-PD-L1 immunotherapy, atezolizumab, in patients with previously treated non-small cell lung cancer.

Foundation Medicine publishes new data in Nature Medicine on bTMB

The new assay, an expanded version of its FoundationACT assay, will include more than 70 genes and genomic biomarkers for microsatellite instability and blood tumor mutational burden.

US Food and Drug Administration Grants Breakthrough Device Designation to Foundation Medicine for New Liquid Biopsy Assay

At the time of admission, the physical examination and laboratory test results were normal, with the exception of a slightly elevated blood tumor marker (CYFRA21-1: 5.2 ng/ml, normal range: 0-3.3 ng/ml).

Early Multiple Primary Lung Cancer without Fluorodeoxyglucose Uptake on Positron Emission Tomography-Computed Tomography and Displaying Different EGFR Molecular Profiles

7.45 (260m): Typhoo (Scr), Max's Boy (3), Blood Tumor (4), Reggie (7), Esther (7), Nutcase (8).

GREYHOUNDS; SPORT IN BRIEF

I have the privilege of working with blood tumor markers like HE4, which aids in detecting ovarian cancer, from a bench top validation (ELISA) to an automated analyzer.

Quo Vadis?

So far, the ACT approach is effective against liquid, or blood tumors, rather than solid tumors, as are found in breast and colorectal cancers, for example.

Breakthrough Treatment for Large B-Cell Lymphoma: The FDA approved CAR T cell therapy, which harnesses the patient's own immune system to fight cancer

Benzene is known to cause hematotoxicity and blood tumors in humans and mice.

Benzene's adverse effects: microarrays reveal breadth of toxicity

The company is developing CAR T products against a range of cancer antigens with the potential to target both solid and blood tumors.

bluebird bio, TC BioPharm to Collaborate to Research, Develop CAR T Cell Cancer Immunotherapies